University of Badji Mokhtar Annaba | Algeria

Author Profile

Early Academic Pursuits

Kheireddine Ouali was born on December 27, 1970, in Annaba, Algeria. He pursued his early education in his hometown before embarking on higher studies. His academic journey led him to specialize in biology and animal physiology, culminating in the attainment of a Doctorat d’État.

Professional Endeavors

Currently holding the prestigious position of Professor, Kheireddine Ouali serves as both an educator and a researcher. He is based at BP12 El Hadjar Annaba 23000, Algeria, and can be reached at 038562004 or via his mobile at 0561097708. His professional responsibilities extend to his role as the Director of the Laboratory of Environmental Biosurveillance, where he oversees significant research projects and initiatives.

Contributions and Research Focus on Oxidative stress and Diabetes

Ouali's research primarily focuses on biology and animal physiology. His contributions to these fields are substantial, with numerous publications and research projects that have advanced understanding and innovation. His work is particularly noted for its emphasis on environmental biosurveillance, addressing critical issues related to environmental health and safety.

Impact and Influence

Kheireddine Ouali has made a profound impact on the scientific community, both within Algeria and internationally. His research findings and academic contributions have influenced policies and practices in environmental health. Additionally, his role as an educator has enabled him to mentor and guide the next generation of scientists and researchers.

Academic Cites

Ouali's academic work has been widely cited in various scientific journals and publications. His research on animal physiology and environmental biosurveillance is frequently referenced by peers, underscoring his influence and the importance of his contributions to these fields.

Legacy and Future Contributions

As a leading figure in his field, Kheireddine Ouali's legacy is marked by his dedication to scientific advancement and education. His future contributions are anticipated to further enhance understanding in biology, animal physiology, and environmental health, ensuring that his impact will continue to be felt for years to come.

Notable Publications

Effect of subacute treatment with bisphenol A on oxidative stress biomarkers and lipid peroxidation in Gambusia affinis mosquitofish 2023(3)

Subchronic toxicity of iron-selenium nanoparticles on oxidative stress response, histopathological, and nuclear damage in amphibian larvae Rana saharica 2023(1)

Tempol a superoxide dismutase mimic reduces cardiac muscle cell death through the control of oxidative stress in streptozotocin-induced diabetes 2023(1)

Effect of contaminated diet with a plant growth regulator “1-methylcyclopropene” on the hematological parameters and liver function of albino Wistar rats 2023(1)

In Vivo and In Silico Studies Assessment of the Effects of Oral Exposure to 1-Methylcyclopropene on Liver Function in Male Albino Rats 2024

Erisa Mwaka | Genetics and Genomics | Best Researcher Award

Posted on 12/07/202412/07/2024 by PencisLeave a Comment

Assoc Prof Dr. Erisa Mwaka | Genetics and Genomics | Best Researcher Award

Makerere University | Uganda

AUTHOR PROFILE

Orcid ID

EARLY ACADEMIC PURSUITS

Mwaka Erisa Sabakaki's academic journey began at Mwiri Primary School, where he earned his Primary Leaving Examination Certificate in 1986. He continued his education at Busoga College Mwiri, obtaining the Uganda Certificate of Education in 1990 and the Uganda Advanced Certificate of Education in 1992. He pursued a Bachelor of Medicine and Bachelor of Surgery at Makerere University, Kampala, from 1992 to 1997. Following this, he achieved a Master of Medicine in Orthopaedic Surgery from Makerere University between 2000 and 2003, where his thesis focused on the clinical and radiological presentation of osteonecrosis of the femoral head among sickle cell patients. He furthered his academic credentials with a Doctor of Philosophy in Medical Science from Fukui University School of Medicine in Japan, concentrating on histo-pathological and immuno-histological findings related to calcium pyrophosphate dihydrate crystal deposition in the ligamentum flavum of the cervical spine.

PROFESSIONAL ENDEAVORS

Mwaka's professional career is multifaceted, combining academic responsibilities, clinical practice, and extensive involvement in research ethics. Since December 2020, he has been an Associate Professor at Makerere University College of Health Sciences, School of Biomedical Sciences, Department of Anatomy. His clinical practice includes serving as an orthopaedic and spine surgeon at Mulago National Referral and Teaching Hospital. Additionally, he has held significant roles, such as the Chair of the Makerere University School of Biomedical Sciences Higher Degrees Research Ethics Committee (SBSHREC), where he oversees the regulation of research involving human participants and study animals.

CONTRIBUTIONS AND RESEARCH FOCUS ON GENETICS AND GENOMICS

Mwaka's contributions to the medical field are substantial, particularly in the areas of anatomy, orthopaedics, bioethics, and health research ethics. He has a notable interest in spine conditions, occupational health, bone health in HIV, and the ethics of medical care, biobanking, and genomics. His research includes supervising graduate studies and conducting his own investigations, with a significant focus on ethical standards and the responsible conduct of research. He is a key member and co-investigator in various training programs, including the Fogarty-funded International Health Ethics Training (IHRET) master's program.

IMPACT AND INFLUENCE

Mwaka has been recognized for his significant contributions to medical education, clinical care, and research. He is a member of multiple professional organizations, including the Uganda Medical Association, Association of Surgeons of Uganda, Uganda Orthopaedic Association, and International Society of Orthopaedic Surgery and Traumatology (SICOT). His involvement in these organizations has enhanced his professional skills and fostered teamwork and communication within the medical community.

AWARDS AND HONORS

Mwaka's excellence in his field has been acknowledged through numerous awards and honors. Notably, he received the Prof. Medi Kawuma Excellence in Medical Ethics Award in 2023 from the Uganda Medical Association, recognizing his outstanding contributions to research, clinical care, and medical education. He has also been honored by the Uganda Orthopaedic Association and the South African Research Ethics Training Initiative (SARETI) for his academic and professional achievements.

ACADEMIC SITES

Mwaka has actively contributed to multiple technical advisory committees and data and safety management boards. His roles include overseeing studies on severe acute malnutrition, HIV outcomes improvement using mobile phone-based support, growth and development in stunted children, clinical trials on natural therapeutics, and respiratory interventions. His work in these areas underscores his dedication to improving health outcomes through research and ethical oversight.

LEGACY AND FUTURE CONTRIBUTIONS

Mwaka's legacy is marked by his dedication to education, clinical excellence, and ethical research practices. His contributions have significantly advanced the fields of orthopaedics, bioethics, and health research ethics. Moving forward, his continued involvement in mentoring and training future medical professionals and researchers will further solidify his impact on the medical community. His role in developing and implementing ethical guidelines for clinical research will ensure the responsible conduct of research and the protection of participants' rights and welfare.

NOTBLE PUBLICATIONS

Informed consent in cancer clinical care: Perspectives of healthcare professionals on information disclosure at a tertiary institution in Uganda 2024(1)

Evaluation of the current status of prosthetic rehabilitation services for major limb loss: a descriptive study in Ugandan Referral hospitals 2024(2)

Research Participants’ Preferences for Individual Results of Pharmacogenomics Research: A Case of a Ugandan HIV Research Institute 2023(2)

A case for routine microbial diagnostics: Results from antimicrobial susceptibility testing in post-traumatic wound infections at a Ugandan tertiary care hospital 2023(2)

Remote consent approaches for mobile phone surveys of non-communicable disease risk factors in Colombia and Uganda: A randomized study2023(1)

Yasser El-Nahhal | Down Syndrome | Outstanding Scientist Award

Posted on 12/07/202412/07/2024 by PencisLeave a Comment

Prof Dr. Yasser El-Nahhal | Down Syndrome | Outstanding Scientist Award

The Islamic University Gaza | State of Palestine

AUTHOR PROFILE

Scopus

Orcid ID

Google Scholar

EARLY ACADEMIC PURSUITS

Dr. Yasser Zeedan EL-Nahhal began his academic journey at Alexandria University, Egypt, where he earned a B.Sc. in Pesticide Chemistry in 1981 and an M.Sc. in Pesticide Chemistry in 1984. His dedication to further education led him to the Hebrew University of Jerusalem, where he completed his Ph.D. in 1999. His thesis focused on developing stabilized and ecologically acceptable herbicide formulations for use in hot and sunny regions, marking the beginning of his commitment to environmental chemistry and eco-toxicology.

PROFESSIONAL ENDEAVORS

Dr. EL-Nahhal's professional career is marked by significant teaching and research positions. He has been a Full Professor at the Faculty of Science at the Islamic University of Gaza since July 21, 2020, after serving as an Associate Professor from January 15, 2015. His postdoctoral research includes work at prestigious institutions such as Michigan State University, Christian-Albrechts-Universität in Germany, and Rutgers University in the USA. His work spans various aspects of pesticide interaction with the environment, focusing on adsorption, water management, and eco-toxicology.

CONTRIBUTIONS AND RESEARCH FOCUS ON DOWN SYNDROME

Dr. EL-Nahhal's contributions to environmental chemistry and eco-toxicology are extensive. His research focuses on:

Environmental Chemistry of Pesticides and Persistent Organic Chemicals: Investigating the behavior and impact of pesticides and other organic chemicals in the environment.
Removal of Pollutants from Soil: Developing methods to remove organic and inorganic pollutants, ensuring safer soil and water interactions.
Bioremediation: Exploring the role of cyanobacteria in the bioremediation of marine pollutants, a critical area for maintaining marine ecosystem health.
Integrated Organic Waste Recycling Systems: Promoting sustainable waste management practices.
Hazardous Waste Management: Addressing the challenges of managing hazardous waste effectively.

IMPACT AND INFLUENCE

Dr. EL-Nahhal's research has had a significant impact on environmental science, particularly in Gaza and beyond. His work on bioremediation and eco-friendly pesticide formulations has contributed to sustainable agricultural practices and environmental protection. He has been a principal investigator and senior researcher in numerous projects, demonstrating his leadership in the field.

ACADEMIC CITES

With a citation index of 3223, an h-index of 31, and an i10-index of 67, Dr. EL-Nahhal's work is widely recognized and respected in the scientific community. His publications and research findings are frequently cited, reflecting the influence and importance of his contributions to environmental science.

LEGACY AND FUTURE CONTRIBUTIONS

Dr. EL-Nahhal's legacy lies in his commitment to environmental sustainability and his extensive research on eco-toxicology. He has supervised numerous Master's theses, guiding the next generation of scientists in Gaza. His future contributions will likely continue to focus on innovative solutions to environmental challenges, furthering his impact on both local and global scales.

TEACHING AND MENTORING

In addition to his research, Dr. EL-Nahhal is dedicated to teaching and mentoring. He teaches courses in Environmental Science, Ecology, Environmental Analysis, Environmental Health, and Toxicology. His mentorship has resulted in the completion of numerous Master’s theses, covering topics such as adsorption and leaching of herbicides, biodegradation of pesticides, eco-toxicity studies, and more.

NOTABLE PUBLICATIONS

Pesticide residues in honey and their potential reproductive toxicity 2020(100)

Pesticide residues in drinking water, their potential risk to human health and removal options 2021(104)

Cardiotoxicity of some pesticides and their amelioration 2021(39)

Data on estimation of health hazards associated with pesticide residues in drinking water 2022(6)

Modelling of impact of presence/absence of suspended particulate organic matter from river and sea and effluent wastewater on fluorescence signal in the coastal area of Gapeau River 2021(7)

Lihua Wang | Inherited Kidney Diseases | Best Researcher Award

Posted on 07/07/202407/07/2024 by PencisLeave a Comment

Mrs. Lihua Wang | Inherited Kidney Diseases | Best Researcher Award

The Second Hospital of Dalian Medical University | China

AUTHOR PROFILE

Scopus

EARLY ACADEMIC PURSUITS

Lihua Wang began her academic journey in clinical medicine, obtaining a 5-year degree from Shandong Medical University in 2007. She furthered her education with a 3-year post-graduate program at Shanghai Jiao Tong University, graduating in 2010. Her key curriculums included a comprehensive array of medical sciences, such as Organic Chemistry, Medical Physics, Cell Biology, Anatomy, Histology and Embryology, Physiology, Biochemistry, Immunology, Microbiology, Pathology, Pathophysiology, Pharmacology, Medical Genetics, Diagnosis, Internal Medicine Science, Surgery Science, Obstetrics and Gynecology Science, Pediatrics Science, Neurology and Psychiatry, Dermatology, Radiation Science, Ophthalmology, Otolaryngology, and Chinese Traditional Medicine.

PROFESSIONAL ENDEAVORS

Lihua Wang's professional career began in November 2010 at The Second Hospital of Dalian Medical University in Liaoning Province, China. She served as a General Practitioner until 2014, treating clinical diseases with a blend of traditional Chinese and Western medicine. Her expertise covered a wide range of areas including Pediatrics, Internal Medicine, Rheumatism, and Immune System diseases.

From November 2014 to 2020, she was promoted to Attending Doctor at the same hospital. In November 2020, she advanced to the position of Assistant Director Physician, a role she continues to hold. With over 15 years of experience, she is particularly skilled in treating complex diseases with traditional Chinese medical science, such as various types of glomerulonephritis, acute kidney failure, and chronic kidney disease.

CONTRIBUTIONS AND RESEARCH FOCUS ON INHERITED KIDNEY DISEASES

Lihua Wang has made significant contributions to the field of nephrology through her research. Her notable publications include:

"Dencichine Ameliorates Renal Injury by Improving Oxidative Stress, Apoptosis, and Fibrosis in Diabetic Rats" published in Life Science.
"Construction of a Drug, miRNA, and Transcription Factor Regulatory Network in Membranous Nephropathy Based on Oxidative Stress-Related Genes" published in the Journal of Taibah University for Science.
"Diagnosis of Membranous Nephropathy with Anti-GBM Glomerulonephritis: A Case Series Report" published in BMC Nephrology.

IMPACT AND INFLUENCE

Dr. Wang's research has significantly impacted the understanding and treatment of nephrological diseases. Her work on oxidative stress, apoptosis, and fibrosis in diabetic rats has provided valuable insights into renal injury amelioration. Additionally, her research on membranous nephropathy has led to the development of a comprehensive regulatory network involving drugs, miRNA, and transcription factors, furthering the understanding of this condition.

ACADEMIC CITES

Dr. Wang's work has been cited in various academic publications, reflecting the influence and relevance of her research in the medical community. Her findings have contributed to the broader body of knowledge in nephrology and related fields.

LEGACY AND FUTURE CONTRIBUTIONS

Lihua Wang's legacy is characterized by her dedication to blending traditional Chinese medicine with modern medical practices to address complex health issues. Her ongoing research and clinical work continue to push the boundaries of medical science, particularly in the treatment of kidney diseases. Looking forward, Dr. Wang aims to expand her research efforts, leveraging her lab platform to conduct innovative studies that will further contribute to the medical field.

PERSONAL ATTRIBUTES

Dr. Wang is passionate, self-confident, honest, dedicated, and hardworking. She thrives under pressure and is committed to continuous learning and innovation in her field. Her ability to work under pressure and her dedication to her profession are key attributes that have driven her success and will continue to do so in the future.

NOTABLE PUBLICATIONS

Dencichine ameliorates renal injury by improving oxidative stress, apoptosis and fibrosis in diabetic rats 2020(12)

Randomized Control Study on Hemoperfusion Combined with Hemodialysis versus Standard Hemodialysis: Effects on Middle-Molecular-Weight Toxins and Uremic Pruritus 2020(9)

Melatonin decreases GSDME mediated mesothelial cell pyroptosis and prevents peritoneal fibrosis and ultrafiltration failure 2024(1)

Diagnosis of membranous nephropathy with Anti-GBM glomerulonephritis: a case series report 2024

Xiang Gui Yang | Clinical Microbiology | Best Researcher Award

Posted on 05/07/202405/07/2024 by PencisLeave a Comment

Xiang Gui Yang | Clinical Microbiology | Best Researcher Award

The First Affiliated hospital of Chengdu Medical College | China

AUTHOR PROFILE

Scopus

EARLY ACADEMIC PURSUITS

Yang Xianggui embarked on his academic journey at Harbin Medical University, where he earned a Bachelor's degree in Medical Laboratory Science. He further advanced his education at Chongqing Medical University, obtaining a Master's degree in Clinical Laboratory Diagnostics from the School of Laboratory Medicine.

PROFESSIONAL ENDEAVORS

Since July 2015, Yang Xianggui has been serving as the Deputy Chief Laboratory Physician at the First Affiliated Hospital of Chengdu Medical College. His primary focus is on research into bacterial resistance mechanisms and virulence, positioning him as a significant contributor to this critical field of medical research.

CONTRIBUTIONS AND RESEARCH FOCUS ON CLINICAL MICROBIOLOGY

Dr. Yang's research endeavors have been substantial and varied, including:

CRISPR/Cas9 Technology: Utilizing CRISPR/Cas9 to knock out the ftsZ gene in bacteria to study the molecular regulatory mechanism of the key enzyme MpI in the peptidoglycan cycle.
Gene Knockout Studies: Investigating the regulatory mechanism of acute-chronic infection transformation based on the nagZ gene knockout in Enterobacter cloacae.
MicroRNA Research: Exploring the application of miR-135 in detecting early-onset chronic kidney disease.
Enzyme and Protein Studies: Examining the correlation between Klebsiella pneumoniae KPC-2 enzyme and OmpK36, and studying the molecular regulatory mechanism of AmpC beta-lactamase, a key enzyme in the peptidoglycan cycle.

IMPACT AND INFLUENCE

Dr. Yang has been the principal investigator on several high-impact research projects funded by notable organizations:

National Natural Science Youth Foundation Project: CRISPR/Cas9 technology study on ftsZ gene knockout.
Sichuan Provincial Natural Science Foundation General Project: Regulatory mechanism study on acute-chronic infection transformation.
Sichuan Provincial Department of Education Fund: Research on miR-135's application in early-onset chronic kidney disease detection.
Chengdu Medical University Fund: Correlation study between Klebsiella pneumoniae KPC-2 enzyme and OmpK36.
Special Fund of the First Affiliated Hospital of Chengdu Medical College: Study on the molecular regulatory mechanism of AmpC beta-lactamase.

ACADEMIC CITES

Dr. Yang has published nine SCI papers as the first author or corresponding author, showcasing his contributions to the scientific community. His work is recognized and cited by peers, reflecting his influence and expertise in bacterial resistance mechanisms and clinical laboratory diagnostics.

LEGACY AND FUTURE CONTRIBUTIONS

Dr. Yang's ongoing research projects and completed studies contribute significantly to the understanding of bacterial resistance and virulence. His legacy is built on his dedication to advancing laboratory medicine through innovative research and collaborative efforts. Future contributions are anticipated in the areas of infection control, molecular diagnostics, and bacterial resistance management, further enhancing his impact on medical science and patient care.

IMPORTANT TOPICS

BACTERIAL RESISTANCE MECHANISMS: Exploring how bacteria develop resistance to antibiotics and identifying potential targets for new treatments.
VIRULENCE FACTORS: Investigating the components that make bacteria pathogenic and how they can be neutralized.
MOLECULAR REGULATORY MECHANISMS: Understanding the intricate molecular pathways that govern bacterial behavior and resistance.
GENE KNOCKOUT TECHNOLOGIES: Utilizing advanced gene-editing tools like CRISPR/Cas9 to study bacterial genetics and physiology.
CLINICAL APPLICATIONS: Translating research findings into practical applications in clinical diagnostics and treatment strategies.

NOTABLE PUBLICATIONS

PCT, IL-6, and IL-10 facilitate early diagnosis and pathogen classifications in bloodstream infection 2023(4)

Resistance of Klebsiella pneumoniae to Phage hvKpP3 Due to High-Molecular Weight Lipopolysaccharide Synthesis Failure 2023(3)

Application of Single-Cell Genomics in Cardiovascular Research 2023(2)

Cefazolin and imipenem enhance AmpC expression and resistance in NagZ-dependent manner in Enterobacter cloacae complex 2023(3)

Candida tropicalis distribution and drug resistance is correlated with ERG11 and UPC2 expression 2021(33)

Wenhan Huang | Bone Cancer Disease | Best Researcher Award

Posted on 05/07/202405/07/2024 by PencisLeave a Comment

Dr. Wenhan Huang | Bone Cancer Disease | Best Researcher Award

Guangdong Provincial People's Hospital | China

AUTHOR PROFILE

Scopus

Google Scholar

EARLY ACADEMIC PURSUITS

Wenhan Huang began his academic journey at Southern Medical University, where he obtained his Bachelor of Clinical Medicine. He continued his education at the same institution, earning a Master of Medicine in Surgery from the Department of Joint Reconstruction and Sports Medicine under the supervision of Professor Yu Zhang. He later pursued a Doctor of Philosophy in Orthopaedics and Traumatology at The Chinese University of Hong Kong (CUHK), where he was guided by Professor Yung Shu-hang Patrick.

PROFESSIONAL ENDEAVORS

Dr. Huang currently serves as an Attending Physician and Research Fellow in Orthopaedics at Guangdong Provincial People’s Hospital and the Guangdong Academy of Medical Sciences. His clinical practice and research focus heavily on knee osteoarthritis, sports injuries, and orthopaedic biomechanics.

CONTRIBUTIONS AND RESEARCH FOCUS ON BONE CANCER DISEASE

Dr. Huang has made significant contributions to the field of orthopaedics through various research initiatives:

Gait Analysis and Biomechanics: He established the Greater Bay Area Gait Alliance to conduct extensive gait examinations for knee osteoarthritis and sports injuries. His work led to the development of a gait diagram concept and the creation of an expert consensus on gait diagram evaluation for knee joint movement function.
Customized Knee Motion Simulator: He developed a knee motion simulator to evaluate patellofemoral joint (PFJ) kinematics and biomechanical changes in ACL reconstructed knee joints, exploring their relationship with PFJ osteoarthritis.
Cadaveric Biomechanical Studies: His studies include investigating the effects of graft tension and posterior tibial loading on PFJ biomechanics during ACL reconstruction.

IMPACT AND INFLUENCE

Dr. Huang's work has garnered recognition and support from various prestigious organizations. His research grants have funded multiple groundbreaking projects:

Gait Analysis and Biomechanics: Establishing the Greater Bay Area Gait Alliance.
Knee Motion Simulator: Development of a customized knee motion simulator system.
Biomechanical Studies: Extensive cadaveric studies on graft tension and PFJ biomechanics.

QUALIFICATIONS & AWARDS

Dr. Huang's dedication to orthopaedics has earned him numerous accolades:

Hong Kong Orthopaedic Association Traveling Scholarships (2017, 2018)
Best Paper Presentation Award in Sports Medicine (2018)
Hong Kong Orthopaedic Association Exchange Ambassador (2019)
APOA Sports Meeting Travel Grant (2019)

ACADEMIC CITES

Dr. Huang is an active member of several international and national societies, including the Orthopaedic Research Society (ORS), International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine (ISAKOS), and the Chinese Society of Clinical Oncology (CSCO). His involvement in these organizations underscores his commitment to advancing orthopaedic research and practice.

LEGACY AND FUTURE CONTRIBUTIONS

Dr. Huang's innovative research and clinical expertise have positioned him as a leading figure in orthopaedics. His ongoing projects, such as exploring the biomechanics of ACL reconstruction techniques, promise to further enhance the understanding and treatment of knee joint disorders. His legacy is marked by his dedication to improving patient outcomes through meticulous research and collaborative efforts within the medical community.

NOTABLE PUBLICATIONS

Design of single-phased magnesium alloys with typically high solubility rare earth elements for biomedical applications: Concept and proof 2023(15)

Transtibial pull-out repair of lateral meniscus posterior root is beneficial for graft maturation after anterior cruciate ligament reconstruction: a retrospective study 2022(9)

Clinical guidelines for microwave ablation of spinal metastases 2022(3)

Comparison of Effectiveness and Safety in Treating Acute Acromioclavicular Joint Dislocation with Five Different Surgical Procedures: A Systematic Review and Network Meta-Analysis 2023(5)

Chronic ACLD Knees with Early Developmental Cartilage Lesions Exhibited Increased Posterior Tibial Translation during Level Walking

Fatemeh Gholizadeh | Plant Stress | Women Researcher Award

Posted on 27/05/202427/05/2024 by PencisLeave a Comment

Dr. Fatemeh Gholizadeh | Plant Stress | Women Researcher Award

HUN-REN Centre for Agricultural Research | Hungary

AUTHOR PROFILE

Scopus

Orcid ID

EARLY ACADEMIC PURSUITS

Fatemeh Gholizadeh began her academic journey with a Bachelor of Science in Horticulture Sciences from Gorgan University of Agricultural Sciences and Natural Resources. She advanced her studies at the same institution, earning a Master of Science in Plant Biotechnology. Her M.Sc. thesis focused on estimating genetic diversity in rice (Oryza sativa L.) genotypes using SSR markers under salinity stress, showcasing her early interest in plant genetics and stress physiology.

PROFESSIONAL ENDEAVORS

Fatemeh's professional journey is marked by her pursuit of a Ph.D. in Plant Biotechnology from Sanandaj University of Kurdistan. Her doctoral research delved into the identification and study of the polyamine oxidase gene family in wheat (Triticum aestivum) and their expression in response to exogenous polyamines and cold treatment. This work highlights her commitment to understanding plant responses to environmental stresses, a critical area in agricultural biotechnology.

CONTRIBUTIONS AND RESEARCH FOCUS ON PLANT STRESS

Throughout her academic career, Fatemeh Gholizadeh has contributed significantly to the field of plant biotechnology. Her research primarily focuses on plant genetics, stress physiology, and biotechnology. By investigating the genetic mechanisms underlying plant responses to environmental stresses, she aims to enhance crop resilience and productivity. Her work on polyamine oxidase genes in wheat and genetic diversity in rice underlines her expertise in molecular biology and plant stress responses.

IMPACT AND INFLUENCE

Fatemeh's research has made a notable impact in the scientific community, particularly in the areas of plant stress physiology and genetic diversity. Her studies provide valuable insights into the genetic and molecular basis of plant responses to abiotic stresses, such as salinity and cold. This research is crucial for developing stress-resistant crop varieties, which is essential for ensuring food security in the face of climate change.

ACADEMIC CITES

Fatemeh Gholizadeh's work has been recognized and cited by peers in the field, reflecting the significance and relevance of her research. Her contributions are documented in various scientific publications and platforms, including her ORCID profile (0000-0002-1518-4629) and Loop profile (2004768). These citations underscore her role in advancing plant biotechnology research.

LEGACY AND FUTURE CONTRIBUTIONS

Looking ahead, Fatemeh Gholizadeh is poised to continue her impactful research in plant biotechnology. Her ongoing work will likely further our understanding of plant genetics and stress responses, contributing to the development of resilient agricultural systems. Her legacy will be defined by her commitment to improving crop performance under adverse conditions, ultimately benefiting global agriculture and food security.

NOTABLE PUBLICATIONS

Genome-wide analysis of the polyamine oxidase gene family in wheat (Triticum aestivum L.) reveals involvement in temperature stress response 2020(21)

Improvement of Drought Tolerance by Exogenous Spermidine in Germinating Wheat (Triticum aestivum L.) Plants Is Accompanied with Changes in Metabolite Composition 2022(6)

Light Spectral Composition Modifies Polyamine Metabolism in Young Wheat Plants 2022(5)

Evaluation of morphological traits of wheat varieties at germination stage under salinity stress 2022(5)

Polyamines-Mediated amelioration of cold treatment in wheat: Insights from morpho-physiological and biochemical features and PAO genes expression analyses 2024

Bin Zhang | Gene Mutation | Best Researcher Award

Posted on 26/05/202426/05/2024 by PencisLeave a Comment

Prof Bin Zhang | Gene Mutation | Best Researcher Award

Jining Medical University | China

AUTHOR PROFILE

Scopus

Google Scholar

EARLY ACADEMIC PURSUITS

Bin Zhang's journey into the world of medical research began with a solid foundation in biomedical sciences. His early academic pursuits were marked by a dedication to understanding complex biological systems and a passion for contributing to the field of oncology. This academic dedication led him to become a young expert recognized under the prestigious Taishan Mount Scholars program in China.

PROFESSIONAL ENDEAVORS

In 2018, Bin Zhang was appointed as a researcher at the Affiliated Hospital of Jining Medical University. Here, he established the tumor metabolism research group, assuming the role of Principal Investigator. Under his leadership, the group has grown to focus on four key research directions: the regulatory mechanisms of tumor stem cells, the specificity of tumor biomacromolecules and energy metabolism, the regulation of energy metabolism by oncogenic gene mutations, and the screening of potential drugs targeting tumor metabolism.

CONTRIBUTIONS AND RESEARCH FOCUS ON GENE MUTATION

Bin Zhang's research has significantly advanced the understanding of tumor metabolism. His work has been published in esteemed journals such as Cell Reports Medicine, Biomaterials, Oncogene, Journal of Experimental & Clinical Cancer Research, and Stem Cells. These publications highlight his team's investigations into the intricate mechanisms of tumor biology and potential therapeutic targets. The research group delves into how tumor stem cells are regulated, how tumor biomacromolecules function, and how mutations in oncogenes affect energy metabolism, all of which are crucial for developing new cancer treatments.

IMPACT AND INFLUENCE

The impact of Bin Zhang's research is reflected in the high citation rate of his publications, with over 5000 citations to date and an H-Index of 34. His work has not only contributed valuable knowledge to the scientific community but has also influenced ongoing research and development in tumor metabolism. Furthermore, Bin Zhang has successfully secured ten patents, two of which have been transferred, demonstrating the practical applications and commercial potential of his research findings.

ACADEMIC CITES

Bin Zhang is also an active member of the academic community, serving as a reviewer for several high-impact journals including Stem Cells and Development, EBioMedicine, Stem Cell Research & Therapy, Molecular Carcinogenesis, and the Journal of Clinical Laboratory Medicine. His expertise is sought after in evaluating cutting-edge research and ensuring the quality of publications in these journals.

LEGACY AND FUTURE CONTRIBUTIONS

Bin Zhang's legacy in the field of tumor metabolism is marked by his innovative research and commitment to advancing cancer treatment. Currently, he is the principal investigator of two general projects funded by the National Natural Science Foundation of China, two projects funded by Shandong Province, and two projects funded by the Postdoctoral Foundation of China. His ongoing work promises to uncover new insights and develop novel therapies, continuing to push the boundaries of cancer research

NOTABLE PUBLICATIONS

A roadmap from research to clinical testing of mesenchymal stromal cell exosomes in the treatment of psoriasis 2023(7)

IL-13/IL-13RA2 signaling promotes colorectal cancer stem cell tumorigenesis by inducing ubiquitinated degradation of p53 2023(4)

Therapeutic Efficacy of Mesenchymal Stem/Stromal Cell Small Extracellular Vesicles in Alleviating Arthritic Progression by Restoring Macrophage Balance 2023(1)

Engineered EVs with pathogen proteins: promising vaccine alternatives to LNP-mRNA vaccines 2024

Arachidonic acid released by PIK3CA mutant tumor cells triggers malignant transformation of colonic epithelium by inducing chromatin remodeling 2024

Paritha Arumugam | Gene Therapy | Best Researcher Award

Posted on 23/05/2024 by PencisLeave a Comment

Dr. Paritha Arumugam | Gene Therapy | Best Researcher Award

Cincinnati Children's Hospital Medical Center | United States

AUTHOR PROFILE

Scopus

Orcid ID

EARLY ACADEMIC PURSUITS

Paritha Arumugam's academic journey began at the University of Madras, Bharathi Women's College, where she earned her B.Sc. in Biochemistry in 1991. She continued her education at the University of Madras, Guindy Campus, obtaining her M.Sc. in Biochemistry in 1993, M.Phil. in Biochemistry in 1994, and Ph.D. in Biochemistry in 1998 under the mentorship of Shyamala Devi, C.S. Her academic excellence was recognized with numerous awards, including the Gold Medal for securing the first rank in her M.Sc. program and various other prestigious prizes from the University of Madras.

PROFESSIONAL ENDEAVORS

Dr. Arumugam's professional career is marked by significant roles in both academic and research settings. She served as a Postdoctoral Research Fellow at the Children’s Hospital Los Angeles (CHLA) from 2004 to 2006, under the guidance of Dr. Punam Malik in the Division of Hematology-Oncology. She later earned an M.S. in Drug Development from the University of Cincinnati in 2011, where she was advised by Kevin L. Skare. Her academic appointments at the University of Cincinnati College of Medicine and Cincinnati Children’s Hospital Medical Center (CCHMC) have been pivotal. She progressed from Research Instructor in Pediatrics (2015-2019) to her current position as an Assistant Professor in Pediatrics at the Translational Pulmonary Science Center, Division of Pulmonary Biology, beginning in October 2019.

CONTRIBUTIONS AND RESEARCH FOCUS ON GENE THERAPY

Dr. Arumugam's research has significantly advanced the fields of biochemistry and molecular biology, with a particular focus on translational pulmonary science. Her work on developing a novel cell transplantation therapy, specifically Pulmonary Macrophage Transplantation, earned her a plenary talk at the NHLBI Celebration of 15 Years of Basic and Translational Progenitor Cell Research in 2023. Her research has garnered numerous awards, including the Excellence in Hemoglobinopathy Research Award from the National Institutes of Health and multiple abstract and travel awards from the American Society of Hematology.

IMPACT AND INFLUENCE

Dr. Arumugam's impact extends beyond her direct research contributions. Her role in advancing clinical practices is underscored by her licensing and certification in Good Clinical Practice for clinical trials involving drugs and devices. Her expertise in conducting investigator-initiated studies according to FDA regulations and GCP has positioned her as a leader in the field, capable of managing investigational agents and overseeing the ethical conduct of clinical trials.

ACADEMIC CITES

Dr. Arumugam's academic excellence has been recognized with several citations and awards throughout her career. Notably, she has been a recipient of the Cincinnati Children’s Innovation Excellence Award in 2023 and the NHLBI Celebration of 15 Years of Basic and Translational Progenitor Cell Research Poster Award. Her scholarly contributions are also highlighted by her selection as a Translational Sickle Scholar by the National Institutes of Health.

LEGACY AND FUTURE CONTRIBUTIONS

Dr. Arumugam's legacy is defined by her dedication to advancing medical science and improving clinical practices. Her pioneering research on pulmonary macrophage transplantation and her contributions to hemoglobinopathy research underscore her commitment to translational science. Looking forward, Dr. Arumugam aims to continue her impactful research, mentor the next generation of scientists, and contribute to significant advancements in pediatric pulmonary biology and therapeutic developments.

NOTABLE PUBLICATIONS

Neutrophil extracellular traps activate IL-8 and IL-1 expression in human bronchial epithelia 2020(52)

FOXM1 nuclear transcription factor translocates into mitochondria and inhibits oxidative phosphorylation 2020(28)

Thrombin-PAR1 signaling in pancreatic cancer promotes an immunosuppressive microenvironment 2021(27)

Role of GM-CSF in regulating metabolism and mitochondrial functions critical to macrophage proliferation 2022(26)

A murine model of hereditary pulmonary alveolar proteinosis caused by homozygous Csf2ra gene disruption 2022(8)

Richard Lu | Neurodegenerative Diseases | Best Researcher Award

Posted on 23/05/202423/05/2024 by PencisLeave a Comment

Prof Richard Lu | Neurodegenerative Diseases | Best Researcher Award

Cincinnati Children's Hospital Medical Center | United States

Author Profile

Scopus

Early Academic Pursuits

Qing Richard Lu embarked on his academic journey with a Bachelor of Science in Biochemistry from Peking Normal University in Beijing, China, which he completed in 1988. Following this, he pursued a Master of Science in Biophysics at Rutgers University, New Jersey, USA, completing his degree in 1993. He continued his studies at Rutgers University, earning a Ph.D. in Biochemistry in 1997 under the mentorship of Dr. Masayori Inouye.

Professional Endeavors

Dr. Lu's professional career began with a postdoctoral fellowship at the Dana-Farber Cancer Institute, Harvard Medical School, from 1997 to 2002. He worked with Dr. Chuck D. Stiles and collaborated with Dr. David Rowitch. In 2002, he joined the UT Southwestern Medical Center as an Assistant Professor in the Department of Developmental Biology, where he held the position of Southwestern Medical Foundation Endowed Scholar in Medical Research. He was promoted to Associate Professor with tenure in 2009 and continued in this role until 2013. In 2013, Dr. Lu joined Cincinnati Children’s Hospital Medical Center and the University of Cincinnati College of Medicine. He currently holds the position of Professor with tenure in the Department of Pediatrics. Additionally, he serves as the Scientific Director of the Brain Tumor Center and Program Leader of the Brain Tumor Program in the Division of Experimental Hematology and Cancer Biology, Cancer & Blood Diseases Institute.

Contributions and Research Focus on Neurodegenerative Diseases

Dr. Lu's research primarily focuses on the molecular and cellular mechanisms underlying brain tumors. His work is significant in understanding the biology of brain cancer and developing new therapeutic strategies. He has made notable contributions to the field of experimental hematology and cancer biology through his research on brain tumor development, progression, and treatment.

Impact and Influence

Throughout his career, Dr. Lu has influenced the field of pediatric oncology and neurobiology. His research has provided insights into the genetic and biochemical pathways involved in brain tumors, contributing to the development of novel therapeutic approaches. His work has been recognized through various academic appointments and endowed scholarships, reflecting his significant impact on medical research.

Academic Cites

Dr. Lu's work has been widely published in numerous scientific journals, and his research findings are frequently cited by peers in the field. His publications contribute to the broader scientific understanding of brain tumors and their treatment, solidifying his reputation as a leading expert in the field.

Legacy and Future Contributions

As a leading figure in pediatric oncology and neurobiology, Dr. Lu's legacy is marked by his commitment to advancing scientific knowledge and improving patient outcomes. His ongoing research efforts and leadership roles at Cincinnati Children’s Hospital Medical Center and the University of Cincinnati College of Medicine continue to shape the future of brain tumor research and treatment. Dr. Lu’s future contributions are expected to further enhance the understanding and management of brain tumors, paving the way for innovative therapeutic solutions and improved patient care.

Notable Publications

Distinct astrocytic modulatory roles in sensory transmission during sleep, wakefulness, and arousal states in freely moving mice 2023(12)

Loss of phosphatase CTDNEP1 potentiates aggressive medulloblastoma by triggering MYC amplification and genomic instability 2023(9)

A road map for the treatment of pediatric diffuse midline glioma 2024(2)

The myelination-associated G protein-coupled receptor 37 is regulated by Zfp488, Nkx2.2, and Sox10 during oligodendrocyte differentiation 2024(1)

BRG1 programs PRC2-complex repression and controls oligodendrocyte differentiation and remyelination 2024